Dodd-Frank and Sarbanes-Oxley Acts

Dodd-Frank and Sarbanes-Oxley: Dodd-Frank and Sarbanes-Oxley are important laws in the business world because they are related to public companies and private companies. In order to enhance the transparency and accountability of listed companies, the Sarbanes-Oxley Act was enacted. Instead, the Dodd-Frank Act was enacted as a network to understand the chaotic evaluation of financial services companies. In fact, these evaluations are often obscured by complex and obscure financial instruments. Recently, an accounting fraud case occurred by senior executives of companies like Enron, which promoted the introduction of the Sarbanes-Oxley Act.

In this article I will explain the invasion of federal law into the field of corporate governance, which was formerly part of the state law. The 2002 Sarbanes-Oxley Act ("SARBOX") and Dodd-Franke are representative examples of this invasion. Both invitations are aimed at protecting the general public - in the Dodd - Frank case, SARBOX and consumers (as a product and credit user) will invest in the general public. Is it correct to create public interests like 'restoring the confidence of investors' that prove that the federal government infringes on corporate governance? I should remember ... more

Veasey: This question may need to define "Recent". The regulatory environment has undergone major changes in the past decade. The Sarbanes - Oxley Act, Dodd - Frank Act, and JOBS Act not only played an important role in promoting compliance reform but also encouraged the adoption of best practices. The Board itself voluntarily strengthened vigilance and best practices. The Delaware State Court recently strictly reviews the decision-making and supervision by the board of directors and management (Caremark), but decision-making still has the principle of long-standing business judgment rules. In this area and supervision / compliance areas the problem only occurs in private lawsuits in the Delaware state court and without the regulatory system it is difficult for plaintiffs to prove Caremark's violation in derivatives or class actions.